Somatuline AutoGel-120mg (Lanreotide Injection) 120mg

Somatuline AutoGel-120mg is a prescription injection containing lanreotide, used for hormone-related conditions. It provides sustained release for targeted therapy. Store between 2-8°C to maintain potency. Always follow healthcare provider guidance for use.

Strength

120mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

IPSEN PHARMA BIOTECH

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Somatuline AutoGel-120mg is used to treat acromegaly and neuroendocrine tumors. It helps manage symptoms by reducing excess growth hormone or hormone-secreting tumors. This long-acting injection supports hormone regulation in adults. Commonly prescribed for conditions requiring somatostatin analog therapy.

Side Effects

This injection works gradually to regulate hormone levels over time. Users may notice reduced symptoms related to hormone imbalances, such as headaches or flushing. The effects are not immediate and build with consistent use. Some may experience mild discomfort at the injection site.

Precautions & Warnings

Keep Somatuline AutoGel-120mg refrigerated between 2-8°C to preserve efficacy. Avoid freezing or exposing to high temperatures. Always handle injections with clean hands and proper technique. Discard any unused portions as directed by your pharmacist.

Avoid Interactions

Lanreotide may interact with medications affecting heart rhythm or blood sugar levels. Caution is advised when combining with other hormone therapies. Alcohol use should be discussed with a healthcare provider. Monitor for changes if taking drugs metabolized by the liver.

Frequently Asked Questions

Lanreotide is used to treat acromegaly and certain neuroendocrine tumors by regulating hormone levels.

It is administered as a deep subcutaneous injection, typically every 28 days. Follow your doctor’s instructions for dosing.

Somatuline AutoGel requires a prescription and is available through licensed pharmacies.

Common effects may include injection site reactions, digestive discomfort, or changes in blood sugar levels.

Store between 2-8°C in the original packaging. Do not freeze or expose to direct sunlight.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.